RESET-MYOSITIS Trademark

Trademark Overview

On Thursday, January 18, 2024, a trademark application was filed for RESET-MYOSITIS with the United States Patent and Trademark Office. The USPTO has given the RESET-MYOSITIS trademark a serial number of 98363318. The federal status of this trademark filing is REGISTERED as of Tuesday, December 9, 2025. This trademark is owned by Cabaletta Bio, Inc.. The RESET-MYOSITIS trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

providing a website featuring information about autoimmune disease
reset-myositis

General Information

Serial Number98363318
Word MarkRESET-MYOSITIS
Filing DateThursday, January 18, 2024
Status700 - REGISTERED
Status DateTuesday, December 9, 2025
Registration Number8061756
Registration DateTuesday, December 9, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 17, 2024

Trademark Statements

Goods and Servicesproviding a website featuring information about autoimmune disease
Pseudo MarkRESETMYOSITIS

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, January 18, 2024
Primary Code044
First Use Anywhere DateFriday, May 31, 2024
First Use In Commerce DateFriday, May 31, 2024

Trademark Owner History

Party NameCabaletta Bio, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19104
Party NameCabaletta Bio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19104
Party NameCabaletta Bio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19104

Trademark Events

Event DateEvent Description
Thursday, January 18, 2024NEW APPLICATION ENTERED
Thursday, May 16, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 13, 2024ASSIGNED TO EXAMINER
Thursday, August 15, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 28, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 17, 2024PUBLISHED FOR OPPOSITION
Tuesday, September 17, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 12, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, April 28, 2025SOU TEAS EXTENSION RECEIVED
Monday, April 28, 2025SOU EXTENSION 1 FILED
Monday, April 28, 2025SOU EXTENSION 1 GRANTED
Monday, April 28, 2025TEAS STATEMENT OF USE RECEIVED
Tuesday, April 29, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, September 20, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 28, 2025USE AMENDMENT FILED
Friday, September 26, 2025STATEMENT OF USE PROCESSING COMPLETE
Thursday, October 16, 2025SU - NON-FINAL ACTION - WRITTEN
Thursday, October 16, 2025NON-FINAL ACTION E-MAILED
Thursday, October 16, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 23, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 29, 2025ASSIGNED TO LIE
Wednesday, October 29, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 29, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 18, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, November 18, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, December 9, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, December 9, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

myositis reset autoimmune disease about information website featuring providing